Log in or Sign up for Free to view tailored content for your specialty!
Gastropsychology News
Online cognitive behavioral therapy may be cost-effective for IBS; quality studies lacking
Internet-delivered cognitive behavioral therapy may be a cost-effective solution to improve symptoms and quality of life in patients with irritable bowel syndrome, according to a systematic review in Journal of Medical Internet Research.
Multidisciplinary care approach benefits endoscopic bariatric therapies
The CDC estimates that nearly half of the adult population in the United States has obesity. Despite its prevalence and potential impact on health, interventions for obesity are difficult to access due to stigma, very few providers specializing in this care and their expense.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Patients with celiac disease report greater dating hesitancy, social anxiety
In this video, Jessica Lebovits, RD, CDN, discusses research that revealed many patients with celiac disease experience negative effects on their dating life, resulting in less adaptive eating attitudes and decreased quality of life.
Emergence of digital therapeutics boosts access to GI behavioral resources
As the field of gastroenterology evolves, gone are the days when a gastroenterologist is expected to meet the needs of every patient.
VIDEO: Brain-gut communication and its role in food intake, obesity epidemic
SAN DIEGO — In a Healio video exclusive, Andres Acosta, MD, PhD, outlines research presented at Digestive Disease Week 2022 that focused on the relationship between gastric function and the regulation of food intake.
Unaddressed anxiety in patients with IBD ‘will impact their disease outcomes’
SAN DIEGO — Anxiety left unaddressed in the context of inflammatory bowel disease care “will impact the disease course and outcomes,” according to a presenter at Digestive Disease Week 2022.
Biologics linked to lower dementia rate in older patients with IBD
SAN DIEGO — Older patients with inflammatory bowel disease who were treated with biologics exhibited a lower incidence of dementia compared with those never treated with biologics, according to data presented at Digestive Disease Week 2022.
Rome Foundation GastroPsych Group discusses progress, vision at DDW 2022
The Rome Foundation GastroPsych Group conducted a hybrid meeting at Digestive Disease Week in San Diego to review progress over the past year and determine goals for the years to come.
Celiac Disease Awareness Month: disease management, dietary care, quality of life and more
May is Celiac Disease Awareness Month, and the Celiac Disease Foundation — along with those in the celiac community — have dedicated the month to raising awareness and funds for critical disease research and advocacy efforts.
Q&A: Survey reveals unmet needs in IBS symptom management, treatment
Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.
-
Headline News
'We're listening': ABIM axes 'confusing' MOC program requirement
December 04, 20244 min read -
Headline News
Zepbound bests Wegovy in head-to-head weight-loss trial
December 04, 20241 min read -
Headline News
Children who attend day care less likely to develop type 1 diabetes
December 03, 20242 min read
-
Headline News
'We're listening': ABIM axes 'confusing' MOC program requirement
December 04, 20244 min read -
Headline News
Zepbound bests Wegovy in head-to-head weight-loss trial
December 04, 20241 min read -
Headline News
Children who attend day care less likely to develop type 1 diabetes
December 03, 20242 min read